Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Optics Express
|
March 18, 2026
Metasurface-enabled polarization-encoded terahertz encryption via angular spectrum intensity modulation
Linyun Luo, Meng Zhao, Yu Hou, et al.
BMC Public Health
|
July 29, 2022
ARIMA and ARIMA-ERNN models for prediction of pertussis incidence in mainland China from 2004 to 2021
Meng Wang, Jinhua Pan, Xinghui Li, et al.
Frontiers in Immunology
|
December 26, 2022
Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
Yaping Chen, Yanhui Xiao, Ying Ye, et al.
Vaccines
|
April 28, 2023
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial
Yanhui Xiao, Xue Guo, Min Zhang, et al.
Nature Communications
|
November 29, 2025
Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children
Xuewen Tang, Yanhui Xiao, Jinhua Chen, et al.
Vaccine
|
August 5, 2020
Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China
Shaohong Yan, Haiping Chen, Zhenguo Zhang, et al.
The Lancet Regional Health. Western Pacific
|
June 7, 2023
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China
Xuewen Tang, Yanhui Xiao, Xuan Deng, et al.
Vaccines
|
July 27, 2022
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus
Yuntao Zhang, Haiping Chen, Jun Lv, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 13, 2023
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China
Yan Xu, Haiping Chen, Binbing Wang, et al.
Vaccine
|
August 5, 2022
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
Haiping Chen, Zhuoying Huang, Shaoying Chang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Optics Express
|
March 18, 2026
Metasurface-enabled polarization-encoded terahertz encryption via angular spectrum intensity modulation
Linyun Luo, Meng Zhao, Yu Hou, et al.
BMC Public Health
|
July 29, 2022
ARIMA and ARIMA-ERNN models for prediction of pertussis incidence in mainland China from 2004 to 2021
Meng Wang, Jinhua Pan, Xinghui Li, et al.
Frontiers in Immunology
|
December 26, 2022
Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
Yaping Chen, Yanhui Xiao, Ying Ye, et al.
Vaccines
|
April 28, 2023
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial
Yanhui Xiao, Xue Guo, Min Zhang, et al.
Nature Communications
|
November 29, 2025
Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children
Xuewen Tang, Yanhui Xiao, Jinhua Chen, et al.
Vaccine
|
August 5, 2020
Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China
Shaohong Yan, Haiping Chen, Zhenguo Zhang, et al.
The Lancet Regional Health. Western Pacific
|
June 7, 2023
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China
Xuewen Tang, Yanhui Xiao, Xuan Deng, et al.
Vaccines
|
July 27, 2022
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus
Yuntao Zhang, Haiping Chen, Jun Lv, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 13, 2023
Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China
Yan Xu, Haiping Chen, Binbing Wang, et al.
Vaccine
|
August 5, 2022
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial
Haiping Chen, Zhuoying Huang, Shaoying Chang, et al.
Page
of 1